Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer

Descripción del Articulo

PURPOSE Helicobacter pylori (HP) and Epstein Barr virus (EBV) infections induce chronic gastritis (CG) and are accepted carcinogenics of gastric cancer (GC). Our objective for this study was to determine the prevalence of these agents and clinicopathological features of GC and CG associated with the...

Descripción completa

Detalles Bibliográficos
Autores: Castaneda C.A., Castillo M., Chavez I., Barreda F., Suarez N., Nieves J., Bernabe L.A., Valdivia D., Ruiz E., Dias-Neto E., Landa-Baella M.P., Bazan Y., Rengifo C.A., Montenegro P.
Formato: artículo
Fecha de Publicación:2019
Institución:Consejo Nacional de Ciencia Tecnología e Innovación
Repositorio:CONCYTEC-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.concytec.gob.pe:20.500.12390/2740
Enlace del recurso:https://hdl.handle.net/20.500.12390/2740
https://doi.org/10.1200/JGO.19.00122
Nivel de acceso:acceso abierto
Materia:Oncology
Cancer Research
http://purl.org/pe-repo/ocde/ford#3.03.08
id CONC_38512d98e469dd475434e48bf75d9a9a
oai_identifier_str oai:repositorio.concytec.gob.pe:20.500.12390/2740
network_acronym_str CONC
network_name_str CONCYTEC-Institucional
repository_id_str 4689
dc.title.none.fl_str_mv Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer
title Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer
spellingShingle Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer
Castaneda C.A.
Oncology
Cancer Research
http://purl.org/pe-repo/ocde/ford#3.03.08
title_short Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer
title_full Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer
title_fullStr Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer
title_full_unstemmed Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer
title_sort Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer
author Castaneda C.A.
author_facet Castaneda C.A.
Castillo M.
Chavez I.
Barreda F.
Suarez N.
Nieves J.
Bernabe L.A.
Valdivia D.
Ruiz E.
Dias-Neto E.
Landa-Baella M.P.
Bazan Y.
Rengifo C.A.
Montenegro P.
author_role author
author2 Castillo M.
Chavez I.
Barreda F.
Suarez N.
Nieves J.
Bernabe L.A.
Valdivia D.
Ruiz E.
Dias-Neto E.
Landa-Baella M.P.
Bazan Y.
Rengifo C.A.
Montenegro P.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Castaneda C.A.
Castillo M.
Chavez I.
Barreda F.
Suarez N.
Nieves J.
Bernabe L.A.
Valdivia D.
Ruiz E.
Dias-Neto E.
Landa-Baella M.P.
Bazan Y.
Rengifo C.A.
Montenegro P.
dc.subject.none.fl_str_mv Oncology
topic Oncology
Cancer Research
http://purl.org/pe-repo/ocde/ford#3.03.08
dc.subject.es_PE.fl_str_mv Cancer Research
dc.subject.ocde.none.fl_str_mv http://purl.org/pe-repo/ocde/ford#3.03.08
description PURPOSE Helicobacter pylori (HP) and Epstein Barr virus (EBV) infections induce chronic gastritis (CG) and are accepted carcinogenics of gastric cancer (GC). Our objective for this study was to determine the prevalence of these agents and clinicopathological features of GC and CG associated with the infection. PATIENTS AND METHODS A single-center cohort of 375 Peruvian patients with GC and 165 control subjects with CG were analyzed. Evaluation of HP and EBV genes was performed through quantitative polymerase chain reaction. RESULTS Prevalence of HP was 62.9% in the whole population and 60.8% in the GC subset. The cagA gene was detected in 79.9%; vacAs1 and vacAm1 alleles in 41.6% and 60.7%, respectively; and concurrent expression of vacAs1 and vacAm1 in 30.4% of infected patients in the whole series. The prevalence of EBV was 14.1% in the whole population and was higher in GC (P , .001). Coinfection of HP and EBV was found in 7.8% and was also higher in GC in univariate (P , .001) and multivariate (P = .011) analyses. Infection rates of HP and EBV were not associated with a geographic location in the whole series. Few clinicopathological features have been associated with infectious status. CONCLUSION Prevalence of HP infection and virulent strains are high in the Peruvian population. Infection by EBV was more frequent in patients with GC. © 2019 by American Society of Clinical Oncology.
publishDate 2019
dc.date.accessioned.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.available.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.issued.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12390/2740
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1200/JGO.19.00122
dc.identifier.scopus.none.fl_str_mv 2-s2.0-85071751339
url https://hdl.handle.net/20.500.12390/2740
https://doi.org/10.1200/JGO.19.00122
identifier_str_mv 2-s2.0-85071751339
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Journal of Global Oncology
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.publisher.none.fl_str_mv American Society of Clinical Oncology
publisher.none.fl_str_mv American Society of Clinical Oncology
dc.source.none.fl_str_mv reponame:CONCYTEC-Institucional
instname:Consejo Nacional de Ciencia Tecnología e Innovación
instacron:CONCYTEC
instname_str Consejo Nacional de Ciencia Tecnología e Innovación
instacron_str CONCYTEC
institution CONCYTEC
reponame_str CONCYTEC-Institucional
collection CONCYTEC-Institucional
bitstream.url.fl_str_mv https://repositorio.concytec.gob.pe/bitstreams/2dabb86c-7a31-4b34-a208-d84dd0758779/download
https://repositorio.concytec.gob.pe/bitstreams/c25c01da-fc58-4470-9206-9b3d78bae6e2/download
https://repositorio.concytec.gob.pe/bitstreams/70c1675e-ad99-4888-853a-1f7d79a84c5c/download
bitstream.checksum.fl_str_mv e43daf22cfdbb832295ac4bd08a8ce36
43de9aac4142614598caad0e9418c382
cd8ee0c5efd3b59f7583e4800c90aa21
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional CONCYTEC
repository.mail.fl_str_mv repositorio@concytec.gob.pe
_version_ 1844883095445045248
spelling Publicationrp07318600rp06447600rp06448600rp07324600rp06456600rp07320600rp07322600rp07323600rp05755600rp06446600rp07319600rp07321600rp07325600rp06444600Castaneda C.A.Castillo M.Chavez I.Barreda F.Suarez N.Nieves J.Bernabe L.A.Valdivia D.Ruiz E.Dias-Neto E.Landa-Baella M.P.Bazan Y.Rengifo C.A.Montenegro P.2024-05-30T23:13:38Z2024-05-30T23:13:38Z2019https://hdl.handle.net/20.500.12390/2740https://doi.org/10.1200/JGO.19.001222-s2.0-85071751339PURPOSE Helicobacter pylori (HP) and Epstein Barr virus (EBV) infections induce chronic gastritis (CG) and are accepted carcinogenics of gastric cancer (GC). Our objective for this study was to determine the prevalence of these agents and clinicopathological features of GC and CG associated with the infection. PATIENTS AND METHODS A single-center cohort of 375 Peruvian patients with GC and 165 control subjects with CG were analyzed. Evaluation of HP and EBV genes was performed through quantitative polymerase chain reaction. RESULTS Prevalence of HP was 62.9% in the whole population and 60.8% in the GC subset. The cagA gene was detected in 79.9%; vacAs1 and vacAm1 alleles in 41.6% and 60.7%, respectively; and concurrent expression of vacAs1 and vacAm1 in 30.4% of infected patients in the whole series. The prevalence of EBV was 14.1% in the whole population and was higher in GC (P , .001). Coinfection of HP and EBV was found in 7.8% and was also higher in GC in univariate (P , .001) and multivariate (P = .011) analyses. Infection rates of HP and EBV were not associated with a geographic location in the whole series. Few clinicopathological features have been associated with infectious status. CONCLUSION Prevalence of HP infection and virulent strains are high in the Peruvian population. Infection by EBV was more frequent in patients with GC. © 2019 by American Society of Clinical Oncology.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - ConcytecengAmerican Society of Clinical OncologyJournal of Global Oncologyinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/4.0/OncologyCancer Research-1http://purl.org/pe-repo/ocde/ford#3.03.08-1Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancerinfo:eu-repo/semantics/articlereponame:CONCYTEC-Institucionalinstname:Consejo Nacional de Ciencia Tecnología e Innovacióninstacron:CONCYTECORIGINALcastaneda-et-al-2019-prevalence-of-helicobacter-pylori-infection-its-virulent-genotypes-and-epstein-barr-virus-in.pdfcastaneda-et-al-2019-prevalence-of-helicobacter-pylori-infection-its-virulent-genotypes-and-epstein-barr-virus-in.pdfapplication/pdf657966https://repositorio.concytec.gob.pe/bitstreams/2dabb86c-7a31-4b34-a208-d84dd0758779/downloade43daf22cfdbb832295ac4bd08a8ce36MD51TEXTcastaneda-et-al-2019-prevalence-of-helicobacter-pylori-infection-its-virulent-genotypes-and-epstein-barr-virus-in.pdf.txtcastaneda-et-al-2019-prevalence-of-helicobacter-pylori-infection-its-virulent-genotypes-and-epstein-barr-virus-in.pdf.txtExtracted texttext/plain40409https://repositorio.concytec.gob.pe/bitstreams/c25c01da-fc58-4470-9206-9b3d78bae6e2/download43de9aac4142614598caad0e9418c382MD52THUMBNAILcastaneda-et-al-2019-prevalence-of-helicobacter-pylori-infection-its-virulent-genotypes-and-epstein-barr-virus-in.pdf.jpgcastaneda-et-al-2019-prevalence-of-helicobacter-pylori-infection-its-virulent-genotypes-and-epstein-barr-virus-in.pdf.jpgGenerated Thumbnailimage/jpeg5804https://repositorio.concytec.gob.pe/bitstreams/70c1675e-ad99-4888-853a-1f7d79a84c5c/downloadcd8ee0c5efd3b59f7583e4800c90aa21MD5320.500.12390/2740oai:repositorio.concytec.gob.pe:20.500.12390/27402025-01-14 22:00:28.225https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessopen accesshttps://repositorio.concytec.gob.peRepositorio Institucional CONCYTECrepositorio@concytec.gob.pe#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="4e246c88-c517-4764-b218-3a34b7f742b7"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer</Title> <PublishedIn> <Publication> <Title>Journal of Global Oncology</Title> </Publication> </PublishedIn> <PublicationDate>2019</PublicationDate> <DOI>https://doi.org/10.1200/JGO.19.00122</DOI> <SCP-Number>2-s2.0-85071751339</SCP-Number> <Authors> <Author> <DisplayName>Castaneda C.A.</DisplayName> <Person id="rp07318" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Castillo M.</DisplayName> <Person id="rp06447" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Chavez I.</DisplayName> <Person id="rp06448" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Barreda F.</DisplayName> <Person id="rp07324" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Suarez N.</DisplayName> <Person id="rp06456" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Nieves J.</DisplayName> <Person id="rp07320" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Bernabe L.A.</DisplayName> <Person id="rp07322" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Valdivia D.</DisplayName> <Person id="rp07323" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Ruiz E.</DisplayName> <Person id="rp05755" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Dias-Neto E.</DisplayName> <Person id="rp06446" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Landa-Baella M.P.</DisplayName> <Person id="rp07319" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Bazan Y.</DisplayName> <Person id="rp07321" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Rengifo C.A.</DisplayName> <Person id="rp07325" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Montenegro P.</DisplayName> <Person id="rp06444" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>American Society of Clinical Oncology</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by-nc-nd/4.0/</License> <Keyword>Oncology</Keyword> <Keyword>Cancer Research</Keyword> <Abstract>PURPOSE Helicobacter pylori (HP) and Epstein Barr virus (EBV) infections induce chronic gastritis (CG) and are accepted carcinogenics of gastric cancer (GC). Our objective for this study was to determine the prevalence of these agents and clinicopathological features of GC and CG associated with the infection. PATIENTS AND METHODS A single-center cohort of 375 Peruvian patients with GC and 165 control subjects with CG were analyzed. Evaluation of HP and EBV genes was performed through quantitative polymerase chain reaction. RESULTS Prevalence of HP was 62.9% in the whole population and 60.8% in the GC subset. The cagA gene was detected in 79.9%; vacAs1 and vacAm1 alleles in 41.6% and 60.7%, respectively; and concurrent expression of vacAs1 and vacAm1 in 30.4% of infected patients in the whole series. The prevalence of EBV was 14.1% in the whole population and was higher in GC (P , .001). Coinfection of HP and EBV was found in 7.8% and was also higher in GC in univariate (P , .001) and multivariate (P = .011) analyses. Infection rates of HP and EBV were not associated with a geographic location in the whole series. Few clinicopathological features have been associated with infectious status. CONCLUSION Prevalence of HP infection and virulent strains are high in the Peruvian population. Infection by EBV was more frequent in patients with GC. © 2019 by American Society of Clinical Oncology.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication> -1
score 13.08006
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).